Targeted therapy of the ipsilesional, or “good” arm, improved motor function, including control and speed, in chronic stroke survivors with severe paresis. In a small randomized clinical trial ...

The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor, or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke, ...

The National Institutes of Health (NIH) halted a treatment arm of Bayer and Johnson & Johnson’s Xarelto (rivaroxaban) in a phase 3 stroke prevention trial after an independent committee flagged safety ...

For nearly five decades, Steven Spielberg has helped define what alien stories mean to movie audiences. Sometimes they arrive as cosmic miracles. Sometimes as existential threats. Sometimes as ...

The tech sector soared as the risk-on trade returned. Amazon said it would spend $200 on capital expenditures next year, a bullish sign for Arm and its peers. Arm's business in the data center is more ...

The National Institutes of Health (NIH) on Tuesday discontinued the low-dose rivaroxaban arm of its ongoing Phase 3 CAPTIVA stroke prevention trial. The primary goal of the trial is to determine if ...

Barack Obama seemingly confirmed the existence of aliens in a podcast, though he later walked back his comments on Instagram. Congress has held multiple hearings on UFOs, now called UAPs, since 2023, ...

IN THE SEMICONDUCTOR industry, Arm is everywhere and nowhere. Designs from the British-based, American-listed, Japanese-controlled firm sit in almost all the world’s smartphones and most other ...

Arm Holdings is rated Buy, driven by a structural shift to Agentic AI, positioning ARM as a foundational AI infrastructure utility. ARM’s data center royalty revenue is doubling year-over-year, with ...

Shares of SoftBank Group Corp jumped after its telecom arm raised its full-year profit outlook. Renewed optimism around Arm Holdings added to bullish sentiment toward the group's AI exposure. Revenue ...